SEKISUI Diagnostics
Jacqueline Weir, PA-C, MSPAS, MPH, currently serves as Principal Clinical Project Lead at SEKISUI Diagnostics since May 2023. Prior to this role, Jacqueline held key positions at Thermo Fisher Scientific as Clinical Trial Manager, overseeing clinical strategies and regulatory submissions, and at Marque Urgent Care as a Physician Assistant, managing acute disease states across various age groups. Jacqueline has experience as an investigator at ProSciento, contributing to numerous clinical trials, and has also worked as a Physician Assistant in endocrinology at UC San Diego and in internal medicine at Encompass Family and Internal Medicine Group, addressing a wide range of chronic and acute conditions. Jacqueline's early career includes a role at the California Department of Public Health focused on childhood obesity studies. Educationally, Jacqueline holds a MSPAS and MPH from Touro University California and a BS in Biology from San Diego State University.
This person is not in any offices
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals